Pindolol
Back to searchMolecule Structure
Scientific Name
Pindolol
Description of the Drug
Pindolol is a beta adrenoceptor antagonist used to treat hypertension, edema, ventricular tachycardias, and atrial fibrillation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00960
http://www.drugbank.ca/drugs/DB00960
Brand Name(s)
Betadren, Pindolol, Visken
Company Owner(s)
Nostrum Laboratories Inc, Sun Pharmaceutical Industries Inc, Idt Australia Ltd, Watson Laboratories Inc, Bayshore Pharmaceuticals Llc, Ani Pharmaceuticals Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Novartis Pharmaceuticals Corp, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | PARTIAL AGONIST | CHEMBL213 |
Beta-2 adrenergic receptor | SINGLE PROTEIN | PARTIAL AGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL5219 | ||
PharmGKB | PA450966 | ||
Human Metabolome Database | HMDB0015095 | ||
DrugBank | DB00960 | ||
PubChem: Thomson Pharma | 14749780 | ||
PubChem | 4828 | ||
Mcule | MCULE-7764948919 | ||
LINCS | LSM-1953 | ||
Nikkaji | J3.439H | J457.020K | J246.149H |
BindingDB | 50019443 | ||
EPA CompTox Dashboard | DTXSID8023476 | ||
DrugCentral | 2176 | ||
ChemicalBook | CB3105373 | ||
Guide to Pharmacology | 91 | ||
rxnorm | PINDOLOL | ||
PubChem: Drugs of the Future | 24714739 | ||
KEGG Ligand | C07445 | ||
ChEBI | 8214 |